These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

48 related items for PubMed ID: 2555982

  • 1. [The influence of endogenous opioids in hypothalamic amenorrhea. Diagnostic and therapeutic aspects].
    Krause B, Möller S, Ulrich U, Göretzlehner G.
    Zentralbl Gynakol; 1989; 111(20):1368-73. PubMed ID: 2555982
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Possibility of ovulation induction using naloxone in women with hypothalamic amenorrhea].
    Krause B, Möller S, Göretzlehner G.
    Zentralbl Gynakol; 1991; 113(22):1221-33. PubMed ID: 1661461
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Changes in LH, FSH, PRL and estradiol after perfusion with naloxone in normal and amenorrheic women].
    Gandar R, Armani J.
    J Gynecol Obstet Biol Reprod (Paris); 1984; 13(7):765-9. PubMed ID: 6441816
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Induction of ovulation with low-dose estrogen-progestin therapy in amenorrheic patients.
    Ylöstalo P, Huhtaniemi I, Reinilä M.
    Int J Fertil; 1982; 27(3):153-9. PubMed ID: 6128320
    [Abstract] [Full Text] [Related]

  • 10. Chronic treatment with the gonadotropin-releasing hormone agonist D-Ser(TBU)6-EA10-LRH for contraception in women and men.
    Nillius SJ, Bergquist C, Wide L.
    Int J Fertil; 1980; 25(3):239-46. PubMed ID: 6108935
    [Abstract] [Full Text] [Related]

  • 11. Induction of ovulation by the chronic administration of naltrexone in hypothalamic amenorrhea.
    Wildt L, Leyendecker G.
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1334-5. PubMed ID: 3571432
    [Abstract] [Full Text] [Related]

  • 12. [The effects of the pulsatile administration of naloxone on the secretion of gonadotrophins in a case of hypothalamo-hypophyseal amenorrhea].
    Armani J, Gandar R, Baldauf JJ.
    J Gynecol Obstet Biol Reprod (Paris); 1985 Jun; 14(3):301-3. PubMed ID: 3928739
    [Abstract] [Full Text] [Related]

  • 13. Ovulation induction and pregnancy in women with hypothalamic amenorrhea treated with intermittent gonadotropin-releasing hormone.
    Corenblum B, Mackin J, Taylor PJ.
    J Reprod Med; 1985 Oct; 30(10):736-40. PubMed ID: 3934370
    [Abstract] [Full Text] [Related]

  • 14. Disparate effects of naloxone in hypothalamic amenorrhoea of athletes.
    Szabó E, Annus J, Zalányi S, Falkay G.
    Funct Neurol; 1987 Oct; 2(3):315-21. PubMed ID: 3319806
    [Abstract] [Full Text] [Related]

  • 15. [Pulsatile substitution with gonadotropin-releasing hormone in the treatment of sterility in hypothalamic amenorrhea].
    Wildt L, Leyendecker G.
    Internist (Berl); 1985 May; 26(5):266-70. PubMed ID: 3891662
    [No Abstract] [Full Text] [Related]

  • 16. Induction of fertile oestrus in cats by administration of hCG and calcium-naloxone.
    Aiudi G, Cinone M, Sciorsci RL, Minoia P.
    J Reprod Fertil Suppl; 2001 May; 57():335-7. PubMed ID: 11787171
    [Abstract] [Full Text] [Related]

  • 17. Decreased central opioid activity in premenstrual syndrome: luteinizing hormone response to naloxone.
    Rapkin AJ, Shoupe D, Reading A, Daneshgar KK, Goldman L, Bohn Y, Brann DW, Mahesh VB.
    J Soc Gynecol Investig; 1996 May; 3(2):93-8. PubMed ID: 8796815
    [Abstract] [Full Text] [Related]

  • 18. Polycystic ovarian disease unmasked by pulsatile GnRH therapy in a subgroup of women with hypothalamic amenorrhea.
    Mattle V, Bilgyicildirim A, Hadziomerovic D, Ott HW, Zervomanolakis I, Leyendecker G, Wildt L.
    Fertil Steril; 2008 Feb; 89(2):404-9. PubMed ID: 17583701
    [Abstract] [Full Text] [Related]

  • 19. Role of dehydroepiandrosterone sulfate as a prehormone for ovarian steroidogenesis.
    Haning RV, Austin CW, Carlson IH, Kuzma DL, Zweibel WJ.
    Obstet Gynecol; 1985 Feb; 65(2):199-205. PubMed ID: 3155830
    [Abstract] [Full Text] [Related]

  • 20. Chronic naltrexone treatment induces desensitization of the luteinizing hormone pulse generator for opioid blockade in hyperprolactinemic patients.
    de Wit W, Schoute E, Schoemaker J.
    J Clin Endocrinol Metab; 1995 May; 80(5):1739-42. PubMed ID: 7745028
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.